DEPO-TESTOSTERONE INJ 100MG/ML SOLUTION

국가: 캐나다

언어: 영어

출처: Health Canada

유효 성분:

TESTOSTERONE CYPIONATE

제공처:

PFIZER CANADA ULC

ATC 코드:

G03BA03

INN (International Name):

TESTOSTERONE

복용량:

100MG

약제 형태:

SOLUTION

구성:

TESTOSTERONE CYPIONATE 100MG

관리 경로:

INTRAMUSCULAR

패키지 단위:

10ML

처방전 유형:

Schedule G (CDSA IV)

치료 영역:

ANDROGENS

제품 요약:

Active ingredient group (AIG) number: 0106401001; AHFS:

승인 상태:

APPROVED

승인 날짜:

2001-06-04

제품 특성 요약

_ _
_DEPO-TESTOSTERONE Product Monograph _
_ _
_Page 1 of 20_
PRODUCT MONOGRAPH
DEPO-TESTOSTERONE
testosterone cypionate injection
100 mg/mL sterile solution
USP
Androgens
Pfizer Canada Inc.
17, 300 Trans-Canada Highway
Kirkland, Quebec H9J 2M5
Date of Revision:
July 12, 2018
Submission Control No: 217239
©
Pfizer Canada Inc., 2018
_ _
_DEPO-TESTOSTERONE Product Monograph _
_Page 2 of 20 _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................4
DOSAGE FORMS, COMPOSITION AND PACKAGING
...............................................4
WARNINGS AND PRECAUTIONS
..................................................................................4
ADVERSE REACTIONS
....................................................................................................8
DRUG INTERACTIONS
....................................................................................................9
DOSAGE AND ADMINISTRATION
..............................................................................10
OVERDOSAGE
................................................................................................................11
ACTION AND CLINICAL PHARMACOLOGY
............................................................12
STORAGE AND STABILITY
..........................................................................................13
SPECIAL HANDLING INSTRUCTIONS
.......................................................................14
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................14
PART II: SCIENTIFIC INFORMATION
...............................................................................15
PHARMACEUTICAL INFO